Marshall Wace LLP Buys New Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
Marshall Wace LLP purchased a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,279 shares of the medical research company’s stock, valued at approximately $749,000. A number of other institutional investors have also recently […]
Marshall Wace LLP purchased a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,279 shares of the medical research company’s stock, valued at approximately $749,000. A number of other institutional investors have also recently […]
